Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | protein phosphatase 2C, putative | 0.0121 | 0.4189 | 0.5 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0156 | 0.5845 | 0.5845 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.005 | 0.0916 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.005 | 0.0896 | 0.0896 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0245 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0245 | 1 | 1 |
Mycobacterium ulcerans | putative regulatory protein | 0.0037 | 0.0305 | 0.5 |
Trichomonas vaginalis | protein phosphatase type 2C, putative | 0.0121 | 0.4189 | 0.5 |
Trichomonas vaginalis | protein phosphatase 2C delta isoform, putative | 0.0121 | 0.4189 | 0.5 |
Entamoeba histolytica | leucine rich repeat / protein phosphatase 2C domain containing protein | 0.0121 | 0.4189 | 0.5 |
Onchocerca volvulus | 0.005 | 0.0896 | 1 | |
Brugia malayi | bHLH-PAS transcription factor | 0.0037 | 0.0305 | 0.0305 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.4182 | 0.4182 |
Brugia malayi | hypoxia-induced factor 1 | 0.0156 | 0.5845 | 0.5845 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 1 | 1 |
Schistosoma mansoni | single-minded | 0.005 | 0.0916 | 1 |
Brugia malayi | hypothetical protein | 0.0169 | 0.6457 | 0.6457 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6457 | 0.6457 |
Brugia malayi | PAS domain containing protein | 0.005 | 0.0916 | 0.0916 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
(functional) | > 9.7298 ug/ml | In vitro cytotoxicity evaluation on human fibroblasts measured by fluorescence after 72h | WHO/TDR. | No reference |
% motility reduction (functional) | = 0 % | Motility reduction assay in Schistosoma mansoni Puerto Rican adult worms | WHO/TDR. | No reference |
% motility reduction (functional) | = 0 % | Motility reduction assay in Onchocerca ochengi adult worms | WHO/TDR. | No reference |
% motility reduction (functional) | = 100 % | Motility reduction assay in Onchocerca ochengi microfilariae | WHO/TDR. | No reference |
IC50 (functional) | = 1.714 ug/ml | In vitro activity against Trypanosoma cruzi in human lung fibroblast measured by colorimetry after 7 days | WHO/TDR. | No reference |
IC50 (functional) | = 1.714 ug/ml | WHO-TDR: Chagas disease | ChEMBL. | No reference |
IC50 (functional) | = 2.828 ug/ml | In vitro activity against Plasmodium falciparum measured by colorimetry after 72h | WHO/TDR. | No reference |
IC50 (functional) | = 2.828 ug/ml | WHO-TDR: Malaria | ChEMBL. | No reference |
IC50 (functional) | = 3.188 ug/ml | In vitro activity against Trypanosoma brucei measured by florescence after 24h | WHO/TDR. | No reference |
IC50 (functional) | = 3.188 ug/ml | WHO-TDR: Human African Trypanosomiasis (HAT) | ChEMBL. | No reference |
IC50 (functional) | > 9.7298 ug/ml | In vitro activity against Leishmania infantum in mouse macrophages measured by cell viability after 5 days | WHO/TDR. | No reference |
IC50 | > 9.7298 ug/ml | WHO-TDR: Cytotoxicity | ChEMBL. | No reference |
IC50 (functional) | > 9.7298 ug/ml | WHO-TDR: Leishmaniasis | ChEMBL. | No reference |
Inhibition (functional) | = 0 % | WHO-TDR: Schistosomiasis | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Leishmania infantum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 | ||
Trypanosoma brucei gambiense | |||
Trypanosoma cruzi | ChEMBL23 | ||
Plasmodium falciparum |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.